These distinctive kinetics of CD14+ MØs and CD1c+ DCs during the course of PD therapy, as well as peritonitis episodes, has implied a different recruitment or differentiation processes, driven by local cytokines/chemokines under steady state and during inflammation. The gene discussed is CD1C; the disease is peritonitis.